scispace - formally typeset
P

P Roques

Researcher at Imperial College London

Publications -  36
Citations -  12906

P Roques is an academic researcher from Imperial College London. The author has contributed to research in topics: Alzheimer's disease & Dementia. The author has an hindex of 24, co-authored 36 publications receiving 12503 citations. Previous affiliations of P Roques include St Mary's Hospital.

Papers
More filters
Journal ArticleDOI

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.

TL;DR: A locus segregating with familial Alzheimer's disease (AD) has been mapped to chromosome 21, close to the amyloid precursor protein (APP) gene as discussed by the authors, which suggests that some cases of AD could be caused by mutations in the APP gene.

Segregation of a missense mutation in the amyloid precursor protein gene with familial alzheimers-disease

TL;DR: It is demonstrated that in this kindred, which shows linkage to chromosome 21 markers, there is a point mutation in the APP gene that causes an amino-acid substitution close to the carboxy terminus of the β-amyloid peptide.
Journal ArticleDOI

Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene

TL;DR: The occurrence of a second allelic variant at codon 717 linked to the Alzheimer's phenotype supports the hypothesis that they are pathogenic mutations.
Journal ArticleDOI

The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families

TL;DR: This work has localized the PS-1 gene to a 75 kb region and present the structure of this gene, evidence for alternative splicing and describe six novel mutations in early onset FAD pedigrees all of which alter residues conserved in the STM26 (Presenilin 2: PS-2) gene.
Journal ArticleDOI

Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region.

TL;DR: A significant increased frequency of the APOE epsilon 4 allele is observed in late-onset and early-onsets of Alzheimer's disease with ages at onset less than 60 and less than 65, suggesting a possible protective effect.